I D Bernstein
Overview
Explore the profile of I D Bernstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
167
Citations
3048
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dahlberg A, Woo S, Delaney C, Boyle P, Gnirke A, Bock C, et al.
Leukemia
. 2015 Mar;
29(9):1948-51.
PMID: 25742749
No abstract available.
2.
Dahlberg A, Brashem-Stein C, Delaney C, Bernstein I
Leukemia
. 2014 Jun;
28(10):2097-101.
PMID: 24903478
No abstract available.
3.
Walter R, Laszlo G, Lionberger J, Pollard J, Harrington K, Gudgeon C, et al.
Leukemia
. 2014 Apr;
28(10):1969-77.
PMID: 24721792
Recent technological advances led to an appreciation of the genetic complexity of human acute myeloid leukemia (AML), but underlying progenitor cells remain poorly understood because their rarity precludes direct study....
4.
Ho P, Alonzo T, Kopecky K, Miller K, Kuhn J, Zeng R, et al.
Leukemia
. 2010 Apr;
24(5):909-13.
PMID: 20376086
Recent whole-genome sequencing efforts led to the identification of IDH1(R132) mutations in acute myeloid leukemia (AML) patients. We studied the prevalence and clinical implications of IDH1 genomic alterations in pediatric...
5.
Walter R, Raden B, Thompson J, Flowers D, Kiem H, Bernstein I, et al.
Leukemia
. 2004 Sep;
18(11):1914-7.
PMID: 15385942
No abstract available.
6.
Ohishi K, Katayama N, Shiku H, Varnum-Finney B, Bernstein I
Semin Cell Dev Biol
. 2003 Mar;
14(2):143-50.
PMID: 12651098
The Notch pathway is a widely utilized, evolutionarily conserved regulatory system that plays a central role in the fate decisions of multipotent precursor cells. Notch often acts by inhibiting differentiation...
7.
Larson R, Boogaerts M, Estey E, Karanes C, Stadtmauer E, Sievers E, et al.
Leukemia
. 2002 Aug;
16(9):1627-36.
PMID: 12200674
We analyzed the safety and efficacy of Mylotarg (gemtuzumab ozogamicin, an antibody-targeted chemotherapy consisting of a humanized anti-CD33 antibody linked to calicheamicin, a potent antitumor antibiotic) in the treatment of...
8.
Ohishi K, Varnum-Finney B, Bernstein I
Int J Hematol
. 2002 Jul;
75(5):449-59.
PMID: 12095143
The hematopoietic system is maintained by a rare population of hematopoietic stem cells (HSC) that are thought to undergo self-renewal as well as continuously produce progeny that differentiate into the...
9.
Pagel J, Matthews D, Appelbaum F, Bernstein I, Press O
Bone Marrow Transplant
. 2002 Jun;
29(10):807-16.
PMID: 12058230
Radiolabeled monoclonal antibodies have been used with encouraging results in conjunction with stem cell transplantation for patients with hematologic malignancies targeting a variety of surface antigens including CD33, CD45 and...
10.
Purton L, Morris J, Bernstein I, Collins S, Kiem H
J Hematother Stem Cell Res
. 2002 Jan;
10(6):815-25.
PMID: 11798508
A major limiting factor in achieving high levels of gene transfer into hematopoietic stem cells is the ability to retain significant repopulating activity of the stem cells during the ex...